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Abstract
Purpose Obesity, a worldwide health problem, is linked to an abnormal gut microbiota and is currently most effectively 
treated by bariatric surgery. Our aim was to characterize the microbiota of high-fat fed Sprague–Dawley rats when subjected 
to bariatric surgery (i.e., vertical sleeve gastrectomy) and posterior refeeding with either a high-fat or control diet. We 
hypothesized that bariatric surgery followed by the control diet was more effective in reverting the microbiota modifications 
caused by the high-fat diet when compared to either of the two factors alone.
Methods Using next-generation sequencing of ribosomal RNA amplicons, we analyzed and compared the composition of the 
cecal microbiota after vertical sleeve gastrectomy with control groups representing non-operated rats, control fed, high-fat 
fed, and post-operative diet-switched animals. Rats were fed either a high-fat or control low-fat diet and were separated into 
three comparison groups after eight weeks comprising no surgery, sham surgery, and vertical sleeve gastrectomy. Half of 
the rats were then moved from the HFD to the control diet. Using next-generation sequencing of ribosomal RNA amplicons, 
we analyzed the composition of the cecal microbiota of rats allocated to the vertical sleeve gastrectomy group and compared 
it to that of the non-surgical, control fed, high-fat fed, and post-operative diet-switched groups. Additionally, we correlated 
different biological parameters with the genera exhibiting the highest variation in abundance between the groups.
Results The high-fat diet was the strongest driver of altered taxonomic composition, relative microbial abundance, and 
diversity in the cecum. These effects were partially reversed in the diet-switched cohort, especially when combined with 
sleeve gastrectomy, resulting in increased diversity and shifting relative abundances. Several highly-affected genera were 
correlated with obesity-related parameters.
Conclusions The dysbiotic state caused by high-fat diet was improved by the change to the lower fat, higher fiber control 
diet. Bariatric surgery contributed significantly and additively to the diet in restoring microbiome diversity and complexity. 
These results highlight the importance of dietary intervention following bariatric surgery for improved restoration of cecal 
diversity, as neither surgery nor change of diet alone had the same effects as when combined.
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Abbreviations
SCD  Standard chow diet
HFD  High-fat diet
D  Diet induced obesity
BS  Bariatric surgery
VSG  Vertical sleeve gastrectomy
NS  No surgery
Introduction
The gut microbiota is considered a metabolic organ 
consisting of more than 500 species of bacteria, viruses, and 
other organisms living in our intestines, involved in the host 
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intestinal immunity and integrity [1]. Additionally, the gut 
microbiota has metabolic functions, regulating homeostasis 
and modifying the capacity for energy harvesting and has 
thus been proposed as a contributor to the development of 
obesity [2–4].
Along with producing dietary-induced obesity (D) in 
rodents [5], the high-fat diet (HFD) causes alterations in 
the microbial community assemblage when compared to 
control animals [6–8]. Obese animals have lower microbial 
diversity and perturbed abundances of the major gut phyla, 
Firmicutes and Bacteroidetes. It has been demonstrated 
that these changes in diversity are more dependent on diet 
than on weight gain or obesity itself [7, 9, 10] and can be 
reversed with calorie/fat restricted diets [11, 12]. The ratio 
of Bacteroidetes:Firmicutes was previously correlated 
to obesity [2, 6] but new analyses claims that no exact 
relationship can be established [13, 14]. Nevertheless, these 
alterations lead to a dysbiotic state, resulting in leaky gut 
and metabolic endotoxemia (i.e., low grade elevation of 
plasma LPS), potential drivers of the inflammatory response 
characteristic of obesity [9, 15, 16].
Bariatric surgery (BS), mainly Roux-en-Y gastric bypass 
(RYGB) and vertical sleeve gastrectomy (VSG), is presently 
the most effective treatment for obesity. Both procedures 
have similarly successful results despite being anatomically 
different: VSG consists of stomach resection and unchanged 
intestinal tract, and RYGB consists of stomach resection 
and modified intestinal tract, the first part of the small 
intestine being bypassed causing also malabsorption [17-
21]. The main benefits associated with BS are a significant 
and sustained weight loss and improved insulin resistance 
[22]. However, BS is also associated with several potential 
complications depending on the specific surgery: RYGB is 
associated with increased risk of malnutrition and blood 
glucose fluctuations, as well as being a more complicated 
surgery; VSG patients have higher risk of developing 
gastroesophageal reflux disease [23–25]. Due to the similar 
benefits with less severe complications VSG popularity as 
the preferred BS is increasing [26]. Studies in both animal 
models and humans have shown that BS causes changes in 
the microbial community, several of which show apparent 
correlation with the health improvements seen following BS 
[8, 27–30].
This is the continuation of a previous article, where rats 
after being fed either a control diet or HFD for 8 weeks 
underwent either no surgery, simulated (Sham) surgery, 
or VSG [18]. Half of the HFD-fed rats were then changed 
to the control diet for the remaining 4 weeks, emulating 
dietary recommendations for weight loss (increased fruit and 
vegetables, reduced fat) after BS [31, 32]. We previously 
found that the combination of diet change and VSG in rats 
exerted a major effect on the weight of body and organs, 
reducing them to control levels. Due to the relationship 
between obesity and gut microbiota previously described, we 
decided to analyze the effects that diet and surgery had on 
the gut microbiome itself. The aim of the current study was 
to analyze the cecal microbiota using 16S RNA analysis, and 
describe what effect the experimental parameters—HFD, 
dietary switch, surgery, or combinations of the above—had 
on the gut microbiome.
Materials and methods
Animals
The animal protocol was approved by the Ethical Committee 
for Animal Experimentation of the University of Lleida 
(CEEA. 04–05/12). Male Sprague–Dawley rats (9 weeks 
old, weight 315.7 ± 5.4 g) from the breeding house of the 
University of Lleida were pair-housed in polypropylene 
cages under controlled conditions (22 °C, 12/12-h day-night 
cycle, 40–78% humidity).
Study design
Eighteen animals were fed a control diet (C group) with a 
calorie composition of 20% protein, 67% carbohydrate, and 
13% fat (Tekland Global, 2014C, Envigo), and 36 animals 
were fed a HFD (D and posterior D + C group) with a calorie 
composition of 18% protein, 21% carbohydrate, and 60% 
fat (TD.06414, adjusted calories 60/fat, Envigo). Detailed 
composition of both diets is found in Online Resources 
1. Food and water were given ad libitum. After 8 weeks, 
animals were divided into three groups (six C and 12 D 
animals per group) and underwent no surgery (NS), Sham, 
or VSG. Animals continued on their designated diet for four 
more weeks, apart from six animals of each D group that 
were then switched back to control diet (D + C), establishing 
the following subgroups: C-NS, C-Sham, C-VSG, D-NS, 
D-Sham, D-VSG, D + C-NS, D + C-Sham, and D + C-VSG 
(Fig.  1). VSG and sham interventions were performed 
according to previously described procedures [18]. In 
brief, VSG animals had 70–80% of their stomach removed 
under anesthesia while Sham animals underwent the same 
operative procedure but their stomach remained intact. 
Both Sham and VSG animals received antibiotic treatment 
(Enrofloxacina, 10 mg/kg every 12 h) for 5 days (2 days pre-
surgery as a prophylactic treatment, and the following three 
days post-surgery). Surgery had a mortality rate of 9.25% 
during the first two days post-surgery.
Sample collection
Animals were sacrificed by decapitation at week 12 after a 
12 h fast. Blood samples were collected in tubes containing 
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EDTA and plasma was obtained through centrifugation 
(2500 rpm, 15 min, 4 °C). Caeca were collected, snap-frozen 
in liquid nitrogen and stored at − 20 °C. Epididymal and 
perirenal adipose tissues were collected, weighed and stored 
at − 20 °C.
DNA extraction
DNA was extracted from cecum samples using either the 
QIAamp Fast DNA Stool Mini kit or the DNA easy Power 
Soil Kit (QIAGEN, Hilden, Germany). The concentration of 
DNA was assessed using the Quant-iT PicoGreen dsDNA 
Assay kit (ThermoFisher, Massachusetts, USA). DNA 
samples were stored at − 20℃.
Sequencing and analysis of 16S amplicon data
Isolated DNA was amplified with forward primer 341F: 
(CCT ACG GGNGGC WGC AG) and reverse primer 805R: 
(GGA CTA CHVGGG TWT CTAAT) targeting the V3—
V4 hypervariable region of the coding sequence for the 
16S small ribosomal RNA, rRNA. Amplified DNA was 
sequenced on an Illumina MiSeq machine, using the MiSeq 
v3.0 reagent kit leading to 2 × 300 bp paired-end reads. 
Initial demultiplexing was done with the default Illumina 
MiSeq Control Software (2.6.2.1). Down-stream quality 
control, trimming, filtering, merging of forward and reverse 
reads, chimera removal and identification of amplicon 
sequence variants (ASV) was performed with the R software 
version 3.4.2 (https ://www.R-proje ct.org), using the DADA2 
R package version 1.6 [33, 34]. Metabolic reconstruction 
from 16  s amplicon data of KEGG pathways ko04973 
(carbohydrate digestion and absorption) and ko00071 (fatty 
acid degradation) was done from normalized to even depth 
ASV abundance tables for the top 100 most abundant taxa 
created using the above described method, followed by 
submission to the Piphillin server using the KEGG database, 
release of October 2018, and a cut-off sequence similarity 
value of 95% [35].
Biochemical parameters
Glucose was enzymatically analyzed in a METROLAB 
2300 auto-analyzer (RAL, Laboratory Techniques, Spain); 
glucagon and leptin were measured using an ELISA 
kit (R&D, USA), insulin and unacylated ghrelin were 
measured using an ELISA kit (Bertin Bioreagent, France), 
all according to the manufacturer’s protocols.
Glucose homeostasis indicators
Glucose homeostasis was measured by the insulin 
sensitivity index (ISI), the homeostatic model assessment 
of insulin resistance (HOMA-IR) and the homeostatic 
model assessment of β cell function (HOMA-β) calculated 
according the formulas: ISI = 1/fasting glucose fasting 
insulin; HOMA-IR = fasting insulin fasting glucose/22.5; 
HOMA-β = 20 × fasting insulin/(fasting glucose − 3.5).
Data analysis and statistics
Body weight gain (BWG) was calculated by subtracting 
initial body weight from measured body weight at posterior 
time. The adiposity index was calculated as the sum of 
epididymal and perirenal adipose tissues/body weight × 
100. Body weight values were expressed as mean ± SEM. 
Differences in BWG were analyzed by a repeated measure 
ANOVA with Mauchly’s sphericity test followed by GG 
corrections, using the R software. Body weight gain at week 
12 and biochemical parameter differences were analyzed by 
a two-way ANOVA followed by a Tukey post-test. Graphics 
and statistical analysis of gut microbiota were done with 
the Phyloseq package version 1.20.0 [36]. Taxa were 
expressed as relative abundances with expressed values as 
the mean of each group. The Alpha diversity was determined 
using Shannon and Simpson indices and differences were 
analyzed by a two-way ANOVA followed by a Tukey 
post-test. Beta diversity was estimated by Non-Metric 
Multidimensional Scaling (NMDS) and differences were 
analyzed by PERMANOVA. The DeSeq2 R package [37] 
was used to analyze differentially abundant taxa on genus 
level (false discovery rate (FDR) < 0.01 and  log2-fold change 
 (log2 FC) >|10|) associated with the various combinations 
of diet and surgery. The correlation analysis between 
differentially abundant genera and biochemical parameters 
was assessed by Spearman’s correlation method using the R 
software, coefficients were plotted on a heatmap using the 
Fig. 1  Experiment design and group distribution. Rats were fed either 
the control diet (red line) or HFD (blue line) for 8 weeks. At week 
eight, each diet group was then divided in three (n = 6), and subjected 
to one of the three surgical situations: No Surgery, Sham surgery or 
VSG. Half of the HFD-fed rats were then switched to the control diet 
(green line). Rats continued the allocated diet until week 12
 European Journal of Nutrition
1 3
corrplot package. Differences were considered significant 
when P values < 0.05.
Results
General parameters
Results on body and organ weight were previously published 
[18] and are thus not described in detail here. Body weight 
gain was significantly higher after 1 week of HFD in the 
D group (P < 0.001) and continued to be so during the 
whole experiment (except D-VSG and D + C-VSG). At the 
end of the experiment, the BWG for D-VSG was close to 
C-NS, while D + C-VSG was similar to both C-Sham and 
C-NS (Fig. 2a). Adiposity index was similar for all the NS 
groups, D + C-Sham, D-Sham, and D-VSG, higher than in 
C-VSG and D + C-VSG. Leptin decreased significantly in 
C-VSG and D + C-VSG groups, while Ghrelin was lower in 
all the D groups. The maintained HFD tended to increase 
insulin levels and thus HOMA-IR but was not significant. 
Surgery had some effect only for the C and the D + C groups, 
especially with respect to ISI, were D + C-VSG showed the 
best insulin sensitivity (Fig. 2b).
Diversity
Alpha diversity—diversity in each group, calculated by 
Shannon and Simpson Indices—ranked the D groups as 
the least diverse, and the control C-NS as the most diverse 
(Fig.  3a). Sham and VSG surgery negatively affected 
diversity in C and D-groups, but combined with the dietary 
switch, increased diversity for D + C. Taken as a whole, 
diet was the main factor affecting alpha diversity, together 
with the combination of diet and surgery, while surgery 
alone had less of an effect (and no effect in the Simpson 
Index) (Two-way ANOVA, P < 0.01).
Non-Metric Multidimensional Scaling (NMDS), based 
on Bray–Curtis dissimilarities, was used to assess the 
beta-diversity—differences in taxonomic abundances 
between samples—(Fig. 3b) showing that diet and VSG 
had a very significant impact (P < 0.001, PERMANOVA). 
Constrained ordination showed diet as the strongest 
factor separating samples on the first, most explanatory 
axis, and thus, the strongest factor driving the separation 
of populations between C and D groups. The D samples 
formed a distinct, and more defined, group compared 
to the other two diets. Interestingly, the D + C groups 
showed less defined clustering, with samples scattered 
intermediately between clusters representing the D and 
C cohorts, most evident for D + C-Sham and D + C-VSG, 
which overlapped with the C-VSG group. Surgery also 
had a significant impact, resulting in a tight clustering for 
C-VSG when compared to the respective NS and Sham.
Modifications in relative abundances of cecal 
microbes
Diet and surgery induced substantial differences between 
groups. The microbiota was dominated by the phyla 
Bacteroidetes and Firmicutes, which accounted for more 
than 80% of the microbiome in all groups (Fig.  4a). 
a b
Fig. 2  a The D group had a higher body weight gain from week one 
(P < 0.001). At week eight, half of the D animals switched from the 
HFD to the control diet, and all were divided into surgery groups NS, 
Sham or VSG. At week 12, VSG had a significantly lower BWG than 
Sham or NS in the same diet group, especially for D + C (P < 0.001). 
b Different parameters at week 12. The adiposity index was lowered 
by the combination of VSG and diet switch. Leptin was affected 
by VSG. Ghrelin was reduced in D groups. Insulin Sensitivity 
Index increased in D + C-VSG. No significant changes were seen in 
Insulin or HOMA-IR. P values < 0.001 (***) and a–c correspond for 
significantly different groups (Tukey post-test)
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On average, the maintained HFD in D increased the 
Bacteroidetes fraction, but this fraction was normalized 
after the switch to the control diet in D + C groups. The 
diet change also increased the relative abundance of 
Verrucomicrobia, up to 16.31%, in the D + C-NS, but not in 
the antibiotic treated D + C-Sham and D + C-VSG groups. 
Importantly, these two groups showed a strong similarity 
at the phyla level to the C-NS and C-Sham groups. On the 
other hand, surgery increased the relative abundance of 
Firmicutes in D-VSG compared with D-NS (42.43% vs 
37.10%, resp.), while reducing Proteobacteria (0.87% vs 
4.05%, resp.). In the C groups, no substantial differences 
were seen between C-NS and C-Sham, but VSG reduced 
the Firmicutes levels (51.41%). At the family level (Fig. 4b), 
the D groups had higher Bacteroidaceae abundance, drastic 
reductions in Bacteroidales_S24-7 (less than 5%) and 
reduced Ruminococcaceae abundance (also observed in 
D + C-NS) compared with C. The family Rikenellaceae 
was reduced after Sham or VSG, but only in HFD-fed 
groups. D + C-NS and D-VSG similarly had higher levels 
of Erysipelotrichaceae (2.65% and 3.92%). VSG reduced 
the amount of several families in the Firmicutes phylum, 
such as Christensenellaceae, Clostridiaceae, Clostridiales, 
and Defluviitalaceae. Diet and surgery significantly 
increased or decreased some genera (mainly belonging to 
the Firmicutes phylum) when compared to their respective 
C group (Online Resource 2). Several Ruminococcaceae 
decreased in both D and D + C in the NS groups, as 
well as several genera belonging to Lachnospiraceae 
(Acetifactor, Cellulosilyticum, and Lachnospiraceae_
NK4A136_group) which also increased in D + C-Sham. 
The groups D + C-VSG, D-Sham and D-VSG had fewer 
significantly different genera with respect to their control 
matching groups. The Lachnospiraceae_NK4A136_group 
was common in all groups but responded differently to each 
experimental situation.
Correlation between cecal bacteria and other 
parameters
To observe possible associations between the 30 genera 
showing highest change in the dataset showing significant 
change and diverse biological parameters, we performed 
a correlation analysis between them. Figure 5 shows a 
plot of Spearman’s correlation coefficient for significant 
correlations. We observe that the genus Akkermansia 
strongly correlated to the adiposity index and to the 
carbohydrate digestion pathway related to the formation 
of short chain fatty acids. Erysipelatoclostridium had 
similar correlations in addition to Blautia. Bacteroides, 
Faecalitalea, and Terrisporobacter being inversely 
correlated with ghrelin.
a b
Fig. 3  Diversity measures. a Shannon and Simpson indices showing 
sample alpha diversity. The bottom and top of the boxplot indicate 
the first and third quartile, whilst the line inside the box show the 
median. Diversity was reduced by both Sham surgery and VSG in 
all groups. D samples had the lowest diversity except for D + C-NS 
in the NS situation. P values < 0.001 (***), P values < 0.01 (**) and 
a–c correspond for significantly different groups (Tukey post-test). b 
Beta diversity. The non-metric Multidimensinal Scaling (NMDS) plot 
for the bacterial communities in our samples based on Bray–Curtis 
dissimilarities. D groups, C-NS and C-VSG formed distinct clusters. 
PERMANOVA analysis: Surgery (P < 0.001), Diet (P < 0.001). D + C 
samples formed less defined clusters, but were very distinct from D 
samples and were overlapping the C-VSG and C-Sham groups
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Discussion
In this work we investigated the effect of HFD, VSG 
(accompanied by dietary switch or not) and change of 
diet alone on the Sprague–Dawley rat cecal microbiota, 
a follow-up of our earlier work reporting on weight loss 
results [18]. The combined effect of diet and surgery had 
distinctive effects on the microbiota in line with previous 
reports [8, 28, 30]. In addition to this, an obvious effect 
attributable to pre-operative antibiotic prophylaxis is 
noted, reflected in the effects observed in the Sham-
operated cohort of this study. This reasoning is entirely 
in line with the ecological theory where, at the species 
level, functional redundancy is prevalent in such complex 
communities. However, the significance is downplayed by 
therapy-oriented efforts in attributing pathophysiology to 
individual microbes, such as in the absence of a direct 
effect (e.g., toxin production by the causative pathogen) 
where the community function (host phenotype) may not 
be reliant on a singular organism. We have thus exclusively 
approached how surgery (VSG, Sham surgery or, No 
Surgery) combined with dietary variables (control diet, 
HFD, or HFD switched to control diet post-operatively) 
affect the gut microbiota.
The relative abundance of the main phyla was 
strongly affected by diet, and high levels of Bacteroidetes 
accompanied by concomitant low levels of Firmicutes 
were noted for the D cohort (Fig. 4a) as shown in previous 
Fig. 4  Relative abundances 
of bacterial composition, a at 
the phylum level, dominated 
by the Bacteroidetes and the 
Firmicutes phyla. Relative 
abundances of bacterial 
composition, b at the family 
level, with phyla separations 
marked with black lines and 
family separations marked 
with white lines. Family names 
in legend grouped by phyla 
(phylums initial letter). Group 
labels were marked according 
the diet: Red for C, Blue for D, 
Green for D + C
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studies [10, 38]. The maintained HFD also altered diversity, 
separating the D populations from both C and D + C, no 
matter the surgical approach (Fig. 3b), and lowered the 
alpha diversity (Fig. 3a), an indication of dysbiosis [39]. 
The HFD is said to have a lesser negative influence on the 
alpha diversity than other obesogenic diets (such as the one 
mimicking the western diet used by Bortolin et al. [40]. 
Nevertheless, we observed a pronounced reduction that 
persisted after the switch of diet alone. Alpha diversity was 
also affected by VSG, but to a lesser degree than by the 
change of diet, although VSG only removes the glandular 
part of the stomach and leaves the intestine intact [28]. 
Nonetheless, both C and D groups subjected to VSG had 
reduced alpha diversity, similar to what has been seen in 
humans and animals [41, 42], but also to Sham surgery, 
suggesting the effects of the antibiotic Enrofloxacina were 
the primary cause rather than the surgery itself. Interestingly, 
the combination of antibiotic and diet change increased 
alpha diversity for D + C-Sham and D + C-VSG. This 
could imply that a wipeout effect from the antibiotic was 
needed to achieve a more beneficial microbiota restoration 
after the change of diet. This highlights the strong, but 
often-neglected effect of pre-operative antibiotics on the 
microbiome (highlighted in a recent review [43]). More 
research is thus warranted towards further understanding of 
how antibiotic choices may be amenable pre-operatively in 
the re-establishment of a healthy microbiota.
The D + C groups were of particular interest in this study 
as the diet switch to the control diet, even in the absence of 
other factors, resulted in major compositional differences 
in the HFD-fed rats showing a partial restoration of the 
original microbiota. This is in line with other studies [4] 
where a significant reduction in the relative abundance of 
Bacteroidetes and an increase in Firmicutes compared to 
D was reported. As we showed previously [18], ‘recovery’ 
(i.e., net weight and adipose tissue reduction) was better 
achieved in the group combining diet switch and VSG. In 
this study, we observed improvements in BWG, adiposity 
index, leptin, ghrelin and ISI, returning to control values in 
the D + C-VSG group (Fig. 2a, b). Furthermore, D + C-VSG 
rat microbiomes had a closer resemblance to the C groups 
on the phylum level (Fig. 4a) but still differed at family level 
(Fig. 4b), proving the difficulties of proper restoration of the 
microbiota after a diet-induced perturbation, especially at 
lower taxonomy levels, as seen in other studies with HFD-
fed rodents [6, 15, 44]. Once more, this remains a strong 
indicator of community-level synergistic effects, and argues 
against single microbial species causality.
While not disregarding the possibility of redundant 
species function, changes in abundance of specific taxa 
warrants attention; Akkermansia muciniphila, the only 
member of Verrucomicrobiaceae, is described as a marker 
of improved host health [45]. This species was elevated in 
D + C-NS (Fig. 4b) and seems to be directly affected by 
antibiotic administration, as levels were not increased in 
D + C-Sham or D + C-VSG. A. mucinphila was positively 
associated with several parameters related to obesity (Fig. 5) 
but also with increased adiposity. Several of the genera 
found in Fig. 5 contain species that produce short chain fatty 
acid (SCFA). The SCFAs are involved in the maintenance 
of the intestinal epithelium and have been associated with 
obesity and its comorbidities, alongside with improvements 
in intestinal inflammation [46–50]. Indeed, we found 
correlations—both negative and positive—between 
significantly changed genera and the chosen parameters, and 
we observed similar correlation patterns for the following 
taxa; (Akkermansia, Blautia and Erysipelatoclostridium, or 
Ruminiclostridium and Ruminiclostridium-6). Again, this 
may highlight the synergistic effects at the community level, 
instead of pin-pointing single species as causative agents.
Fig. 5  Graphic representation of the Spearman correlation 
coefficients between the significantly altered genera obtained by 
DESeq and different parameters such as adiposity index, biochemical 
parameters, and KEGG pathways. Positive correlations are shown in 
green color and negative correlations in red color. The color intensity 
and the circle size are proportional to the correlation coefficients. 
Only genera with significant correlations (< 0.05) are shown
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To maximize the weight loss associated with VSG and 
stabilize the microbiome, a diet-switch combined with 
probiotic administration may maximize health gains by 
counteracting HFD effects and reduce body weight [39, 
51]. The aforementioned A. mucinphila is a proposed 
probiotic, implicated in combating obesity and metabolic 
syndrome [45, 51]. Accordingly, any prospective probiotic 
cocktail devised to facilitate weight loss would likely 
require extensive testing in multiple dietary backgrounds. 
Another line of reasoning regarding optimal weight loss 
after BS is the effect of VSG on SCFA-producers, resulting 
in reductions of butyrate and decreased LPS translocation 
(leaky gut) relevant to tight junction regulation in the 
intestinal epithelium [40]. Clearly, more work is needed 
to clarify the nature of probiotics, SCFA-producers and 
several other organisms in host physiology, but also and 
perhaps more importantly, the intricate structures and 
relationships between and among taxa at the community 
level. Approaching exact numbers and true abundances will 
require more in-depth analyses combining deep sequencing 
and reverse transcriptomics to identify actively dividing 
populations stimulated by each intervention.
The difficulties associated with extending results from 
animal models to human interventions are diverse and 
widely acknowledged. Rodents allow for the inclusion of 
controls necessary for the optimal evaluation of multiple 
variables and their effects on gut microbiota. However, to 
facilitate easier comparisons in such studies, a need exists 
to standardize diets. Such improved diets are currently being 
developed in several instances [13], as the standard HFD is 
an inadequate representation of western food habits, believed 
to be responsible to some extent for the obesity pandemic. 
Also, an additional no-surgery antibiotic-treated group 
would have been useful in evaluating this effect, and opens 
up avenues for further investigation on future studies.
In conclusion, this study provides evidence that a 
controlled diet following VSG is key to increasing alpha 
diversity and restoring the HFD-perturbed taxonomomic 
composition of the microbiota. It highlights the effect of 
antibiotic exposure in the pre-operative stage, hinting at 
its importance in microbiome modulation caused by the 
procedure. Gut microbiota alterations may be beneficial 
during recovery of healthy body weight after bariatric 
surgery. Further studies are needed to elucidate the intricate 
relationship that gut microbiota, diet, weight loss, antibiotics 
and BS have. Modulation may represent a new plausible 
target in improving the outcome of interventions against 
obesity.
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